Ligand Pharmaceuticals Inc (NASDAQ:LGND)

55.07
Delayed Data
As of Feb 27
 -0.75 / -1.34%
Today’s Change
41.99
Today|||52-Week Range
80.21
+3.50%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 82.00, with a high estimate of 116.00 and a low estimate of 46.00. The median estimate represents a +48.90% increase from the last price of 55.07.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.27
Sales
$13.5M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -55.00%
 
 
 
 
 
 
Growthannually 41.23%
 
 
 
 
 
 

Sales

Growthquarterly -41.16%
 
 
 
 
 
 
Growthannually 26.19%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account